Skip to content
Open access

Therapeutic approach to acute coronary syndromes caused by scad: insights from the serbian (RS) SCAD registry

Oct 2026 · European Heart Journal · 0 citations

Abstract

Spontaneous coronary artery dissection (SCAD) is a non-atherosclerotic cause of acute coronary syndrome, predominantly affecting younger women. Optimal management, particularly the role of PCI, remains debated, with outcomes varying across angiographic subtypes. We conducted a multicenter registry including 130 patients with angiographically confirmed SCAD from 14 PCI centers, followed during hospitalization, at 30 days, and at 1 year. Clinical presentation (STEMI/NSTEMI), SCAD type (1–4, including 2a/2b), management strategy (conservative vs PCI), TIMI flow, procedural details, low-molecular-weight heparin (LMWH) use, discharge therapy, and major adverse cardiovascular events (MACE) were analyzed. Mean age was 47.8 years; 85% were female. STEMI occurred in 68%. Hypertension (49%), dyslipidemia (46%), and active smoking (42%) were common. Conservative therapy was applied in 63 patients (48%), while 67 (52%) underwent PCI, including stent implantation and/or balloon-only angioplasty (POBA). Among PCI patients, the most common angiographic patterns were type 2 (n=18, mainly 2a), type 4 (n=10), type 1 (n=7). Pre-procedural TIMI flow varied by subtype; TIMI 3 flow was not achieved in all patients after intervention. Among 62 patients who achieved TIMI 3 flow, 24% underwent PCI (stent and/or POBA), while 76% achieved TIMI 3 flow without any procedure. LMWH data were available for all 130 patients; 75 (58%) received therapy, mostly short-term (1–2 doses in 43 patients). Extended LMWH dosing (3–6 doses) was used in 11, 8–10 doses in 7, 12–16 doses in 3, and 22–28 doses in 2 patients. At discharge, therapy included DAPT (n=92, 73%), beta-blockers (n=53, 42%), statins (n=49, 39%), ACE/ARBs (n=38, 30%), aspirin (n=31, 25%), and P2Y12 inhibitors (n=3, 2%). In-hospital MACE occurred in 31 patients (24%), with 8% mortality; 30-day and 1-year MACE were 8% and 8%, respectively. Prior heart disease, previous coronary interventions, and statin therapy independently predicted in-hospital MACE. Namely, MACE occurred in 17% of PCI-treated patients at 30 days and in 8% at 1 year. This first SCAD registry from an Eastern transitional country shows that PCI and DAPT were used more frequently than recommended by guidelines. Conservative management was associated with better short-term outcomes, emphasizing that invasive procedures are not always required. Timely and accurate diagnosis, along with judicious use of LMWH and other therapies, is crucial to optimizing outcomes.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.